Concepedia

Botulinum toxin A in the treatment of trigeminal neuralgia

Jian-Hua Xia, Caihong He, Haifeng Zhang, Yajun Lian, Yuan Chen, Chuanjie Wu, Yunqing Ma

International Journal of Neuroscience · 2015 · 41 citations · 20 references

DOI

Abstract

BTX-A treatment can significantly relieve the pain in trigeminal neuralgia patients; improve anxiety, depression, and sleep; and increase the quality of life. BTX-A treatment is a safe and effective method to treat classical trigeminal neuralgia.

References

20

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

John E. Ware, Cathy D. Sherbourne · PubMed · 1992 · 34K citations

, , +22

The MOS 36-ltem Short-Form Health Survey (SF-36)

John E. Ware, Cathy D. Sherbourne · Medical Care · 1992 · 29.1K citations

, , +14

Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity

Cruz Morenilla‐Palao, Rosa Planells‐Cases, Nuria García‐Sanz et al. · Journal of Biological Chemistry · 2004 · 425 citations · Full text

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm

Mitchell F. Brin, Stanley Fahn, Carol Moskowitz et al. · Movement Disorders · 1987 · 417 citations

The burden of neuropathic pain: results from a cross‐sectional survey

Anne M. McDermott, Thomas Toelle, David J. Rowbotham et al. · European Journal of Pain · 2005 · 368 citations